Abstract |
This study assesses viremia, provirus and blood cytokine profile in naturally FIV-infected cats treated with two distinct protocols of interferon omega (rFeIFN-ω). Samples from FIV-cats previously submitted to two single-arm studies were used: 7/18 received the licensed/subcutaneous protocol (SC) while 11/18 were treated orally (PO). Viremia, provirus and blood mRNA expression of interleukin (IL)-1, IL-4, IL-6, IL-10, IL-12p40, Interferon-γ and Tumor Necrosis Factor-α were monitored by Real-Time qPCR. Concurrent plasma levels of IL-6, IL-12p40 and IL-4 were assessed by ELISA. IL-6 plasma levels decreased in the SC group (p = 0.031). IL-6 mRNA expression (p = 0.037) decreased in the PO group, albeit not sufficiently to change concurrent plasma levels. Neither viremia nor other measured cytokines changed with therapy. Proviral load increased in the SC group (p = 0.031), which can be justified by a clinically irrelevant increase of lymphocyte count. Independently of the protocol, rFeIFN-ω seems to act on innate immunity by reducing pro-inflammatory stimulus.
|
Authors | Rodolfo O Leal, Solange Gil, Ana Duarte, David McGahie, Nuno Sepúlveda, Maria M R E Niza, Luís Tavares |
Journal | Research in veterinary science
(Res Vet Sci)
Vol. 99
Pg. 87-95
(Apr 2015)
ISSN: 1532-2661 [Electronic] England |
PMID | 25747956
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2015 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cytokines
- Immunologic Factors
- Interferon Type I
- Interleukin-12 Subunit p40
- Interleukin-6
- RNA, Messenger
- Recombinant Proteins
- interferon omega 1
- Interleukin-4
|
Topics |
- Administration, Oral
- Animals
- Cat Diseases
(blood, immunology, virology)
- Cats
(virology)
- Cytokines
(blood)
- Feline Acquired Immunodeficiency Syndrome
(blood, drug therapy, immunology)
- Immunodeficiency Virus, Feline
(immunology)
- Immunologic Factors
(administration & dosage, pharmacology, therapeutic use)
- Injections, Subcutaneous
- Interferon Type I
(administration & dosage, pharmacology, therapeutic use)
- Interleukin-12 Subunit p40
(blood)
- Interleukin-4
(blood)
- Interleukin-6
(blood)
- RNA, Messenger
(blood)
- Recombinant Proteins
(administration & dosage, pharmacology, therapeutic use)
- Treatment Outcome
- Viral Load
(drug effects, immunology)
- Viremia
(blood, immunology, veterinary)
|